Michel L, Denizot Y, Thomas Y, Jean-Louis F, Heslan M, Benveniste J, Dubertret L
INSERM U 312, Laboratorie de Dermatologie, Hôpital Henri Mondor, Créteil, France.
J Invest Dermatol. 1990 Nov;95(5):576-81. doi: 10.1111/1523-1747.ep12505563.
The production of the inflammatory mediator paf-acether (paf) from human epidermal cells was investigated in vitro. Human epidermal cells, freshly isolated from normal skin or in culture, were incubated in Tyrode's buffer containing 0.25% lipid-free bovine serum albumin in the presence of 2 microM calcium ionophore A23187, at 37 degrees C, for 1 to 60 min. Paf production slightly began at the first min of stimulation, was significant after 10 min, reached a maximum at 20 min (251 +/- 25 pg/l X 10(6) cells, mean +/- 1 SD), and decreased thereafter. About 50% of the paf amount produced by epidermal cells was recovered in supernatants. Addition of the non-acetylated paf precursor 1-O-octadecyl-sn-glycero-3-phosphocholine, i.e., lyso-paf, at 0.1 microM to epidermal cells during A23187-stimulation did not alter this production. In contrast, addition of acetyl-coenzyme A at 0.1 mM enhanced paf production by 5 times. The material produced by epidermal cells was identical to synthetic paf because: 1) the aggregation of aspirin-treated and ADP-insensitive washed rabbit platelets it induced was inhibited by BN 52021, an antagonist of the paf putative receptor; 2) the factor was inactivated by phospholipase A2 but was insensitive to lipase from Rhizopus arrhizus; 3) it exhibited the same retention time as synthetic paf during standard and reverse-phase (RP) high-pressure liquid chromatography (HPLC) elution. The paf precursors, i.e., lyso-paf and 1-O-alkyl-2-acyl-sn-glycero-3-phosphocholine, were also detected in epidermal cells, stimulated with A23187 or not. As determined by RP-HPLC analysis and confirmed by gas chromatography analysis, these precursors and the paf produced by epidermal cells exhibited more than 90% of a hexadecyl chain at the sn-1 position of the molecule. The present results demonstrate the synthesis and release of paf by normal human epidermal cells. Paf production within the epidermis might account for the development of cutaneous inflammation and the pathogenesis of many skin disorders.
体外研究了人表皮细胞炎性介质血小板活化因子(PAF)的产生。将从正常皮肤新鲜分离或处于培养状态的人表皮细胞,在含有0.25%无脂牛血清白蛋白的台氏缓冲液中,于2 microM钙离子载体A23187存在的情况下,37℃孵育1至60分钟。PAF的产生在刺激的第1分钟时略有启动,10分钟后显著增加,在20分钟时达到峰值(251±25 pg/l×10⁶个细胞,平均值±1个标准差),此后下降。表皮细胞产生的PAF量约50%可在上清液中回收。在A23187刺激期间,向表皮细胞中添加0.1 microM的非乙酰化PAF前体1-O-十八烷基-sn-甘油-3-磷酸胆碱,即溶血PAF,不会改变这种产生。相反,添加0.1 mM的乙酰辅酶A可使PAF的产生增加5倍。表皮细胞产生的物质与合成PAF相同,因为:1)它诱导的经阿司匹林处理且对ADP不敏感的洗涤兔血小板聚集被PAF假定受体的拮抗剂BN 52021抑制;2)该因子被磷脂酶A2灭活,但对根霉脂肪酶不敏感;3)在标准和反相(RP)高压液相色谱(HPLC)洗脱过程中,它与合成PAF具有相同的保留时间。在有或无A23187刺激的表皮细胞中也检测到了PAF前体,即溶血PAF和1-O-烷基-2-酰基-sn-甘油-3-磷酸胆碱。通过RP-HPLC分析确定并经气相色谱分析证实,这些前体以及表皮细胞产生的PAF在分子的sn-1位置具有超过90%的十六烷基链。目前的结果证明了正常人表皮细胞可合成并释放PAF。表皮内PAF的产生可能与皮肤炎症的发展以及许多皮肤疾病的发病机制有关。